new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Ono Pharmaceutical Co Ltd patents

Recent patent applications related to Ono Pharmaceutical Co Ltd. Ono Pharmaceutical Co Ltd is listed as an Agent/Assignee. Note: Ono Pharmaceutical Co Ltd may have other listings under different names/spellings. We're not affiliated with Ono Pharmaceutical Co Ltd, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "O" | Ono Pharmaceutical Co Ltd-related inventors




Date Ono Pharmaceutical Co Ltd patents (updated weekly) - BOOKMARK this page
03/30/17Quinoline derivative
03/30/17Monoclonal antibodies to programmed death 1 (pd-1)
03/02/17Biomarker for diagnosis of irritable bowel syndrome
02/23/17Immunopotentiative composition
02/23/17(2r)-2-propyloctanoic acid for functional brain disease
02/23/17Immunopotentiative composition
02/02/17Trk-inhibiting compound
01/19/17Compound having selective ep2 agonist activity
11/17/16Fused imidazole compounds
11/03/16Prophylactic agent and/or therapeutic agent for diffuse large b-cell lymphoma
10/27/16Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof
10/06/16Bicyclic compound and use thereof for medical purposes
10/06/16Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases
09/29/16Trk-inhibiting compound
09/15/16Purinone derivative hydrochloride
09/15/16Pyrrolo pyrimidine derivative
09/01/16Drug-eluting stent graft
08/18/16Methods of producing anamorelin hydrochloride having controlled chloride content
08/18/16Methods of producing anamorelin hydrochloride having controlled chloride content
08/11/16Methods of producing anamorelin hydrochloride having controlled chloride content
07/28/16Phenyl derivative
06/16/16Quinoline derivative
06/09/16Immunopotentiative composition
06/09/16Immunopotentiative composition
05/26/16Alxr agonist compound
02/11/16Phenyl derivative
02/04/16Tetrahydrocarboline derivative
01/07/16Trk-inhibiting compound
10/01/15Prophylactic agent and/or therapeutic agent for diffuse large b-cell lymphoma
10/01/15Purinone derivative hydrochloride
08/20/15Tetrahydrocarboline derivative
08/20/15Advanced heart failure treatment material as myocardial/cardiovascular regeneration device
08/20/15Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes
08/13/15Dosing regimen of sedative
08/06/15Amine salt and crystals thereof
07/16/15Immunopotentiative composition
06/18/15Methods for treating cancer using anti-pd-1 antibodies
06/04/15Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases
06/04/15Compounds
05/07/15Combination therapy of an anti cd20 antibody with a btk inhibitor
05/07/15Phenyl derivative
04/30/15Substance specific to human pd-1
04/23/15Trk-inhibiting compound
04/23/15Bicyclic compound and use thereof for medical purposes
04/16/15Tricyclic compound and use thereof
04/02/15Immunopotentiative composition
04/02/15Use of immunesuppressant receptor
04/02/15Purinone derivative
03/12/15Methods of producing anamorelin hydrochloride having controlled chloride content
12/04/14Phenylacetic acid compound
11/06/14Purinone derivative hydrochloride
11/06/14Methods for treating cancer using anti-pd-1 antibodies
10/23/14Immunopotentiative composition
09/25/14Compound capable of binding s1p receptor and pharmaceutical use thereof
08/21/14Phenyl derivative
08/07/14Therapeutic agent for autoimmune diseases comprising pd-1 agonist
06/26/14Left ventricular diastolic function improving agent
06/19/14Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
06/19/14Compound for treating cartilage disorders
03/13/14Chemokine receptor antagonists and use thereof
03/13/14Bicyclic compound and use thereof for medical purposes
02/20/14Method for producing five-membered ring-containing compound
02/06/14Method of treating of gastroesophageal reflux disease
01/23/14Aminocarboxylic acid derivative and medicinal use thereof
12/26/13Tetrahydrocarboline derivative
Patent Packs
12/05/13Bicyclic compound and use thereof for medical purposes
11/21/13Bicyclic compound and use thereof for medical purposes
09/26/13Tricyclic compound and use thereof
09/19/13Sustained release composition containing sdf-1
08/29/13Endogeneous repair factor production accelerators
08/29/13Phenylacetic acid compound
08/22/13Purinone derivative
07/18/13Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
06/27/13Substance specific to human pd-1
06/06/13Agent for regeneration and/or protection of nerves
05/02/13Tetrahydrocarboline derivative
04/11/13Crystalline forms of 4, 4'- [4-fluoro-7-( ethynyl)-2-methyl-1h-indole-1,3-diyl] dibutanoic acid, 4,4'-[2-methyl-7-( ethynyl)-1h-indole-1, 3-diyl] dibutanoic acid, and 4,4'-[4-fluoro-2-methyl-7- ( ethynyl)-1h-indole-1, 3-diyl] dibutanoic acid
04/04/13Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
03/14/13Use of immunesuppressant receptor
01/31/13Phenylacetic acid compound
Patent Packs
12/27/12Chemokine receptor antagonists and use thereof
12/13/12Remedy for cartilage-related diseases
10/25/12Multimer of extracellular domain of cell surface functional molecule
08/16/12Chemokine receptor antagonists and use thereof
08/09/12Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient
07/19/12Heart-slowing drug containing short-acting beta-blocker as teh active ingredient
06/21/12Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/07/12Soluble protein and utilization of the same
05/17/12Bicyclic compound and use thereof for medical purposes
04/26/12Compound having spiro-bonded cyclic group and use thereof
04/19/12Novel imidazopyridine compound
04/12/12Lpa receptor antagonist
04/12/12Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
03/15/12Compound having s1p receptor binding potency and use thereof
02/02/12Novel polypeptide, cdna encoding the same, and use thereof
11/17/11Substance specific to human pd-1
08/25/11Tricyclic compound and use thereof
06/23/11Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
06/16/11Compound containing basic group and use thereof
05/05/11Aminocarboxylic acid derivative and medicinal use thereof
03/24/11Use of immunesuppressant receptor
03/24/11Percutaneous absorption preparation
03/10/11Agent for regeneration and/or protection of nerves
03/03/11Spiropiperidine compound and medicinal use thereof
01/27/11Compound capable of binding s1p receptor and pharmaceutical use thereof
01/27/11Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide
01/20/11Blood flow promoters for cauda equina tissues
12/30/10Crystal comprising (2r)-2-propyloctanoic acid and amine
12/23/10Sustained release preparation for tissue regeneration therapy
11/25/10Dnas encoding tnf receptor family members
Social Network Patent Pack
11/11/10Novel polypeptide, cdna encoding the same, and use thereof
10/21/10Chemokine receptor antagonist and medical use thereof
10/21/10Sustained release composition containing sdf-1
10/14/10Spiro-piperidine compounds and medicinal use thereof
09/30/10Lpa receptor antagonist
09/23/10Soluble protein and utilization of the same
09/02/10Nitrogen-containing heterocyclic compounds and medicinal use thereof
07/22/10Bicyclic heterocyclic compound
06/24/10Ethynylindole compounds
06/03/10Bicyclic heterocyclic compound
Patent Packs
05/06/108-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
04/08/10Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
03/25/10Therapeutic agent for urinary excretion disorder
03/11/10Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
02/18/10N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for it's preparation
02/18/10Adhesive preparation
02/04/10Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
01/14/10Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient
12/31/09Compound having cyclic group bound thereto through spiro binding and use thereof
12/24/09Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredient
12/03/09Immunopotentiative composition
11/19/09Therapeutic agent for psychoneurotic disease
11/12/09Bicyclic heterocyclic compound
11/05/09Aminocarboxylic acid derivative and medicinal use thereof
10/22/09Substance specific to human pd-1
09/17/09Nitrogenous heterocyclic compound and medicinal use thereof
09/10/09Agent for regeneration and/or protection of nerves
09/10/09Agent for reduction of bleeding in cerebrovascular disorder
08/13/09Therapeutic agent for acute cerebral infarct
07/02/09Basic group-containing compound and use thereof
06/18/09Use of immunesuppressant receptor
06/11/09Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis
05/28/09Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient
05/21/09Nitrogenated heterocyclic derivative , and pharmaceutical agent comprising the derivative as active ingredient
05/07/09Compound containing basic group and use thereof
03/19/09Trenadermal absorption preparation
03/19/09Substance that specifically recognizes pd-1
02/05/09Therapeutic agent for functional brain disease







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ono Pharmaceutical Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ono Pharmaceutical Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';